Antibiotics: Practice Pearls for the Emergency Department Physician

Faculty

Needs Statement

Antibiotics: Practice Pearls for the Emergency Department Physician has been developed to provide an overview of the general principles of antibiotic therapy and includes a review the currentclasses of antibiotics available to the emergency department (ED)physician and outlines their place in the clinical armamentarium. Aspects such as indications, dosing schedules, and common adverse effects will be discussed.

Target Audience

This activity has been developed for emergency medicine physiciansand other healthcare professionals involved in the diagnosis and treatment of patients with infectious diseases (ID) presenting to the emergency department.

Objectives

Upon completion of this activity, participations should be better able to:
1. Recognize the key issues of managing patients with common ID disorders presenting in the ED and treat patients appropriately against a background of increasing antibiotic resistance;
3. Outline currently available and emerging antibiotics and discuss the criteria for appropriate antibiotic selection in the ED.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and P-Value Communications. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Paterson serves on the speakers bureau for AstraZeneca, Cubist Pharmaceuticals, Elan Pharmaceuticals, Inc, and Merck & Co, Inc.; has received research grants from AstraZeneca, Elan Pharmaceuticals, Inc, Merck & Co, and Pfizer, Inc.; and has received consultation fees from Acureon Pharma, Johnson & Johnson, and Merck & Co, Inc.

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and P-Value Communications. Supported by an unrestricted educational grant from Ortho-McNeil Pharmaceutical.